TRPV2 and breast carcinoma: In addition, via activating TRPV2 and PI3/Akt signaling, and then inducing recruitment of TRPV2 from intracellular vesicles to the plasma membrane of pseudopodia, LL-37 promotes proliferation and growth of breast cancer cells (Farabaugh et al., 2016).